Expert Perspectives: Evidence-Based Applications of Polynucleotides (PNs) in Aesthetic Medicine and Dermatology
2
Issued Date
2026-01-01
Resource Type
eISSN
11787015
Scopus ID
2-s2.0-105027514007
Journal Title
Clinical Cosmetic and Investigational Dermatology
Volume
19
Start Page
1
End Page
9
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Cosmetic and Investigational Dermatology Vol.19 (2026) , 1-9
Suggested Citation
Rho N.K., Chilukuri S., Chan G., Kim M.J., Shin J., Suwanchinda A. Expert Perspectives: Evidence-Based Applications of Polynucleotides (PNs) in Aesthetic Medicine and Dermatology. Clinical Cosmetic and Investigational Dermatology Vol.19 (2026) , 1-9. 9. doi:10.2147/CCID.S557226 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/114377
Title
Expert Perspectives: Evidence-Based Applications of Polynucleotides (PNs) in Aesthetic Medicine and Dermatology
Author(s)
Corresponding Author(s)
Other Contributor(s)
Abstract
Polynucleotides (PNs) are increasingly used in aesthetic dermatology, supported by emerging clinical evidence and growing interest in restorative approaches to skin treatment aiming to improve skin conditions. This expert opinion article brings perspectives from an international panel of dermatologists and aesthetic physicians on the use of PNs (Rejuran<sup>®</sup>, PharmaResearch, South Korea) across dermatological indications. The proposed mechanism of action of PNs involves the formation of a hydrophilic, scaffold-like matrix that may support tissue remodeling and hydration. This article highlights the clinical applications of PNs across four indications: skin hydration and rejuvenation; structural support through deep-plane injections; barrier repair in rosacea and eczema; and scar remodeling. For each, the authors provide suggested treatment protocols based on real-world use, including guidance on injection techniques and anatomical targets. PNs have demonstrated a favorable safety profile, with no reported cases of granuloma or vascular occlusion in the literature to date. Their biocompatibility and tolerability make them a promising option, particularly for sensitive or barrier-compromised skin. However, the current evidence base remains limited, and further studies, including randomized trials and histological validation, are needed. This article provides practical clinical guidance while highlighting areas for future research and standardization in the aesthetic use of PNs.